Title: 2025-2026 Regular Session HB 533 PN 0526 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN0526
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HB 533 PN 0526 Bill Text (HTM) PRINTER'S NO. 526 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.533 Session of 2025 INTRODUCED BY McNEILL, WAXMAN, MADDEN, GIRAL AND HOHENSTEIN, FEBRUARY 10, 2025 REFERRED TO COMMITTEE ON HEALTH, FEBRUARY 10, 2025 AN ACTAmending the act of April 17, 2016 (P.L.84, No.16), entitled "An act establishing a medical marijuana program; providing for patient and caregiver certification and for medical marijuana organization registration; imposing duties on the Department of Health; providing for a tax on medical marijuana organization gross receipts; establishing the Medical Marijuana Program Fund; establishing the Medical Marijuana Advisory Board; establishing a medical marijuana research program; imposing duties on the Department of Corrections, the Department of Education and the Department of Human Services; and providing for academic clinical research centers and for penalties and enforcement," in preliminary provisions, further providing for definitions.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The definition of "serious medical condition" in section 103 of the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, is amended to read:Section 103. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:* * *1234567891011121314151617181920212223 "Serious medical condition." Any of the following:(1) Cancer, including remission therapy.(2) Positive status for human immunodeficiency virus or acquired immune deficiency syndrome.(3) Amyotrophic lateral sclerosis.(4) Parkinson's disease.(5) Multiple sclerosis.(6) Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity and other associated neuropathies.(7) Epilepsy.(8) Inflammatory bowel disease.(9) Neuropathies.(10) Huntington's disease.(11) Crohn's disease.(12) Post-traumatic stress disorder.(13) Intractable seizures.(14) Glaucoma.(15) Sickle cell anemia.(16) Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain.(17) Autism.(17.1) A condition deemed a serious medical condition by a practitioner.(18) Other conditions that are recommended by the advisory board and approved by the secretary under section 1202.* * *Section 2. This act shall take effect in 60 days.20250HB0533PN0526 - 2 - 123456789101112131415161718192021222324252627282930


================================================================================

Raw Text:
2025-2026 Regular Session HB 533 PN 0526 Bill Text (HTM) PRINTER'S NO. 526 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.533 Session of 2025 INTRODUCED BY McNEILL, WAXMAN, MADDEN, GIRAL AND HOHENSTEIN, FEBRUARY 10, 2025 REFERRED TO COMMITTEE ON HEALTH, FEBRUARY 10, 2025 AN ACTAmending the act of April 17, 2016 (P.L.84, No.16), entitled "An act establishing a medical marijuana program; providing for patient and caregiver certification and for medical marijuana organization registration; imposing duties on the Department of Health; providing for a tax on medical marijuana organization gross receipts; establishing the Medical Marijuana Program Fund; establishing the Medical Marijuana Advisory Board; establishing a medical marijuana research program; imposing duties on the Department of Corrections, the Department of Education and the Department of Human Services; and providing for academic clinical research centers and for penalties and enforcement," in preliminary provisions, further providing for definitions.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The definition of "serious medical condition" in section 103 of the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, is amended to read:Section 103. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:* * *1234567891011121314151617181920212223 "Serious medical condition." Any of the following:(1) Cancer, including remission therapy.(2) Positive status for human immunodeficiency virus or acquired immune deficiency syndrome.(3) Amyotrophic lateral sclerosis.(4) Parkinson's disease.(5) Multiple sclerosis.(6) Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity and other associated neuropathies.(7) Epilepsy.(8) Inflammatory bowel disease.(9) Neuropathies.(10) Huntington's disease.(11) Crohn's disease.(12) Post-traumatic stress disorder.(13) Intractable seizures.(14) Glaucoma.(15) Sickle cell anemia.(16) Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain.(17) Autism.(17.1) A condition deemed a serious medical condition by a practitioner.(18) Other conditions that are recommended by the advisory board and approved by the secretary under section 1202.* * *Section 2. This act shall take effect in 60 days.20250HB0533PN0526 - 2 - 123456789101112131415161718192021222324252627282930